Eliana MC Tacconi - Concepedia

Author

Eliana MC Tacconi

Also Known As

E Tacconi, E. Tacconi, Eliana M C Tacconi, Eliana M. C. Tacconi, Eliana M.C. Tacconi, Eliana MC Tacconi, Eliana Tacconi, Elisa Tacconi

Publications

Citations

H-Index

Concepts

All Affiliations

University of Oxford CRUK/MRC Oxford Institute for Radiation Oncology Centre National de la Recherche Scientifique Inserm Université de Strasbourg

About

Eliana MC Tacconi is an author at University of Oxford specializing in medicine, cancer epidemiology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	836
2	Natural Sciences	1	1	237
3	Public Health	1	1	599
4	Biochemistry	1	1	237
5	Epidemiology	1	1	599

Eliana MC Tacconi

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
The complete genome sequence of the Gram-positive bacterium Bacillus subtilis Frank Kunst, Naotaka Ogasawara, Ivan Moszer, Nature	1997	3.7K
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey, The Lancet Oncology Primary Tumour SubtypeEpidemiologyCancer EpidemiologyCovid-19 PrevalenceMedicine	2020	599
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds J. Zimmer, Eliana MC Tacconi, Cecilia Folio, Molecular Cell	2015	256
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics A. Chaikuad, Eliana MC Tacconi, J. Zimmer, Nature Chemical Biology Molecular PharmacologySlow Binding KineticsSignal TransductionBiochemistryNatural Sciences	2014	237
<scp>BRCA</scp> 1 and <scp>BRCA</scp> 2 tumor suppressors protect against endogenous acetaldehyde toxicity Eliana MC Tacconi, Xianning Lai, Cecilia Folio, EMBO Molecular Medicine	2017	68
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma Daniel R. McGowan, Michael Skwarski, Kevin M. Bradley, European Journal of Cancer	2019	41
Chlorambucil targets <scp>BRCA</scp> 1/2‐deficient tumours and counteracts <scp>PARP</scp> inhibitor resistance Eliana MC Tacconi, Sophie Badie, Giuliana De Gregoriis, EMBO Molecular Medicine	2019	35
The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studies Filipa Landeiro, Callum Harris, David G. Groves, The Lancet Healthy Longevity	2024	26
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells Rebecca A. Dagg, Gijs Zonderland, Emilia Puig Lombardi, Nature Communications	2021	11

Page 1